“Risk of de novo or secondary cancer after solid organ or allogeneic haematopoietic stem cell transplantation”
Author:
Funder
Danmarks Grundforskningsfond
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Link
http://link.springer.com/content/pdf/10.1007/s00432-019-03039-2.pdf
Reference43 articles.
1. Aagaard T, Reekie J, Roen A, Daugaard G, Specht L, Sengelov H et al (2019) Development and validation of a cycle-specific risk score for febrile neutropenia during chemotherapy cycles 2-6 in patients with solid cancers: the (CSR) FENCE score. Int J Cancer. https://doi.org/10.1002/ijc.32249
2. Adami J, Gabel H, Lindelof B, Ekstrom K, Rydh B, Glimelius B et al (2003) Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 89(7):1221–1227
3. Allin KH, Bojesen SE, Nordestgaard BG (2009) Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol 27(13):2217–2224
4. Allin KH, Bojesen SE, Nordestgaard BG (2016) Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population. Int J Cancer 139(7):1493–1500
5. Billups K, Neal J, Salyer J (2015) Immunosuppressant-driven de novo malignant neoplasms after solid-organ transplant. Prog Transplant 25(2):182–188
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Skin cancer risk after hematopoietic stem cell transplantation: a systematic review and meta‐analysis;International Journal of Dermatology;2024-07-10
2. Cancer incidence in immunocompromised patients: a single-center cohort study;BMC Cancer;2023-01-09
3. Stem Cell Therapy in Cancer;Targeted Cancer Therapy in Biomedical Engineering;2023
4. Early‐ and late‐onset posttransplant lymphoproliferative disorders among adult kidney and liver transplant recipients;European Journal of Haematology;2022-07-14
5. Immune Activation, Exhaustion and Senescence Profiles as Possible Predictors of Cancer in Liver Transplanted Patients;Frontiers in Oncology;2022-06-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3